Democratizing access to rapid, high-quality biomanufacturing with portable CMC
Accelerating clinical impact requires innovative outsourcing. Through parallel integration of our development platform with preclinical drug discovery, our comprehensive discovery-to-IND program offers a completely new path for drug developers that is faster, easier, and more predictable.
We are a growing team of drug development professionals who share a passion for speed to clinical impact through collaboration.
